Wallin R, Hall T R, Hutson S M
Department of Biochemistry, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27103.
J Biol Chem. 1990 Apr 15;265(11):6019-24.
This paper presents the first purification of the branched chain aminotransferase (EC 2.6.1.42) from rat heart mitochondria. The enzyme has been purified from the 100,000 x g supernatant obtained after sonication and ultracentrifugation of rat heart mitochondria. A combination of open column chromatography, high pressure liquid chromatography (HPLC), and discontinuous polyacrylamide disc gel electrophoresis was used. The key step in the procedure was hydrophobic interaction chromatography on HPLC. The final purification step was polyacrylamide disc gel electrophoresis where the enzyme appeared as a doublet. When electroeluted from the gel, each of these bands had the same specific activity demonstrating that there are two forms of the purified enzyme which differ slightly in electrical charge. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, these two enzyme forms appeared as a single band with a molecular mass of 43 kDa. Size exclusion chromatography on Sephacryl S-100 identified the enzyme as a 50-kDa protein. These experiments argue against the existence of a dimeric form of this enzyme. The ratio of enzyme activity with leucine (0.84), valine (0.88), or glutamate (0.66) as amino acid substrate versus isoleucine remained constant throughout the purification procedure. Specific activity of the final preparation was 66 units/mg of enzyme protein. Polyclonal antibodies against the purified enzyme were raised in rabbits. On an immunoblot the antiserum recognized a 43-kDa protein in the 100,000 x g supernatant from a rat heart mitochondrial sonicate but did not recognize any proteins in rat brain cytosol. Quantitative immunodot assay resulted in an estimated enzyme content of about 100 micrograms of branched chain aminotransferase protein/g of heart, wet weight. Finally, 97% of the heart branched chain aminotransferase activity could be neutralized by the antiserum, but the antiserum would not neutralize aminotransferase activity in brain cytosol. These data suggest that close sequence homology does not exist between the two proteins.
本文首次报道了从大鼠心脏线粒体中纯化支链氨基转移酶(EC 2.6.1.42)的方法。该酶是从大鼠心脏线粒体经超声处理和超速离心后得到的100,000×g上清液中纯化出来的。采用了开放柱色谱、高压液相色谱(HPLC)和不连续聚丙烯酰胺圆盘凝胶电泳相结合的方法。该过程的关键步骤是HPLC上的疏水相互作用色谱。最后的纯化步骤是聚丙烯酰胺圆盘凝胶电泳,此时酶呈现为双重条带。从凝胶上进行电洗脱时,这些条带中的每一条都具有相同的比活性,表明纯化后的酶有两种形式,其电荷略有不同。在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上,这两种酶形式呈现为一条分子量为43 kDa的单一条带。用Sephacryl S-100进行尺寸排阻色谱分析表明该酶是一种50 kDa的蛋白质。这些实验表明该酶不存在二聚体形式。在整个纯化过程中,以亮氨酸(0.84)、缬氨酸(0.88)或谷氨酸(0.66)作为氨基酸底物时的酶活性与异亮氨酸的活性之比保持恒定。最终制剂的比活性为66单位/毫克酶蛋白。用纯化后的酶在兔体内制备了多克隆抗体。在免疫印迹中,抗血清识别大鼠心脏线粒体超声处理后的100,000×g上清液中的一种43 kDa蛋白质,但不识别大鼠脑细胞质中的任何蛋白质。定量免疫斑点测定法估计心脏中支链氨基转移酶蛋白的含量约为100微克/克心脏湿重。最后,97% 的心脏支链氨基转移酶活性可被抗血清中和,但该抗血清不能中和脑细胞质中的氨基转移酶活性。这些数据表明这两种蛋白质之间不存在紧密的序列同源性。